\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ significant\\ for\\ a\\ fib\\ with\\ distant\\ heart\\ sounds\\.\ \(0\)\
\-\ treatment\\ was\\ achieved\\ by\\ surgical\\ evacuation\\ of\\ pericardial\\ effusion\\.\ \(0\)\
\-\ pa\\ and\\ lateral\\ chest\\ x\\-ray\\:\\ \\ an\\ enlarged\\ cardiac\\ sillouette\\ is\\ demonstrated\\ with\\ a\\ water\\-bottle\\ shape\\.\\ \\ on\\ the\\ lateral\\ view\\,\\ a\\ density\\ following\\ the\\ border\\ of\\ the\\ heart\\ is\\ seen\\ anteriorly\\ next\\ to\\ a\\ lucent\\ margin\\.\\ \ \(0\)\
\-\ chest\\ ct\\:\\ \\ a\\ large\\ pericardial\\ effusion\\ is\\ demonstrated\\ with\\ anterior\\ parietal\\ pericardial\\ thickness\\ maximally\\ 2\\ mm\\ without\\ pericardial\\ enhancement\\.\ \(0\)\
\-\ pericardial\\ effusion\\,\\ possibly\\ dressler\\'s\\ syndrome\\.\ \(0\)\
\-\ the\\ differential\\ for\\ findings\\ seen\\ on\\ cxr\\ include\\ pericardial\\ effusion\\,\\ dilated\\ cardiomyopathy\\,\\ chf\\,\\ and\\ aortic\\ dissection\\.\ \(0\)\
\-\ the\\ differential\\ causes\\ for\\ pericardial\\ effusion\\ include\\ infectious\\,\\ autoimmune\\,\\ neoplastic\\,\\ drug\\ induced\\,\\ metabolic\\,\\ sarcoidosis\\,\\ pancreatitis\\,\\ and\\ trauma\ \(0\)\
\-\ 76\\ yo\\ male\\ presented\\ with\\ le\\ swelling\\ and\\ pain\\.\\ \\ pt\\ had\\ mi\\ and\\ ptca\\ 3\\ months\\ prior\\ and\\ had\\ been\\ sob\\ since\\ that\\ time\\ for\\ which\\ he\\ was\\ treated\\ with\\ increasing\\ doses\\ of\\ lasix\\ for\\ presumed\\ chf\\ without\\ relief\\.\\ \\ pt\\ was\\ also\\ on\\ coumadin\\ for\\ chronic\\ atrial\\ fibrillation\\ with\\ inr\\ in\\ therapeutic\\ range\\.\ \(0\)\
\-\ a\\ pericardial\\ effusion\\ is\\ an\\ increase\\ in\\ fluid\\ within\\ the\\ space\\ between\\ the\\ visceral\\ and\\ parietal\\ pericardium\\.\\ \\ it\\ is\\ the\\ most\\ common\\ abnormality\\ of\\ the\\ pericardium\\.\\ \\ normally\\,\\ 20cc\\ of\\ fluid\\ is\\ within\\ this\\ space\\,\\ but\\ 200cc\\ is\\ needed\\ for\\ identification\\ on\\ plain\\ film\\ which\\ is\\ demonstated\\ by\\ thickening\\ of\\ the\\ pericardial\\ stripe\\ greater\\ than\\ 2\\-3mm\\ or\\ differential\\ density\\ sign\\.\\ the\\ differential\\ density\\ sign\\ is\\ the\\ lucent\\ margin\\ along\\ the\\ lateral\\ or\\ posterior\\ heart\\ border\\ seen\\ in\\ 63\\%\\ of\\ pericardial\\ effusions\\.\\ \\ although\\ this\\ sign\\ is\\ more\\ sensitive\\ than\\ the\\ thickened\\ pericardial\\ stripe\\ seen\\ in\\ 15\\%\\ of\\ patients\\ with\\ pericardial\\ effusions\\,\\ it\\ is\\ less\\ specific\\.\\ \\ plain\\ film\\ also\\ demonstrates\\ a\\ water\\-bottle\\ configuration\\ of\\ the\\ cardiac\\ sillouette\\.\ \(0\)\
\-\ other\\ modalities\\ can\\ also\\ detect\\ pericardial\\ effusions\\.\\ \\ echocardiography\\ can\\ detect\\ effusions\\ less\\ than\\ 50cc\\ usually\\ posteriorly\\,\\ less\\ than\\ 100cc\\ anteriorly\\ and\\ posteriorly\\,\\ greater\\ than\\ 100cc\\ around\\ the\\ entire\\ ventricle\\.\\ \\ ct\\ can\\ detect\\ loculated\\ pericardial\\ effusions\\.\\ \\ mr\\ demonstrates\\ a\\ pericardial\\ stripe\\ \\>4mm\\ and\\ will\\ have\\ a\\ better\\ characterization\\ of\\ the\\ pericardial\\ fluid\\.\\ \\ \ \(0\)\
\-\ dressler\\â\\€\\™s\\ syndrome\\ consists\\ of\\ a\\ pleural\\ effusion\\ and\\ pericardial\\ effusion\\ developing\\ about\\ 2\\â\\€\\“8\\ weeks\\ after\\ acute\\ myocardial\\ infarction\\.\\ pericardial\\ effusion\\ may\\ be\\ serous\\ or\\ serosanguinous\\,\\ and\\ although\\ rare\\,\\ it\\ can\\ cause\\ cardiac\\ tamponade\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pericardial\\:\\ 0\\.20079658480152196\ \(0\)\
\-\ effusion\\:\\ 0\\.07093341087827333\ \(0\)\
\-\ effusions\\:\\ 0\\.052926834074186774\ \(0\)\
\-\ sillouette\\:\\ 0\\.04279377875711892\ \(0\)\
\-\ water\\-bottle\\:\\ 0\\.04279377875711892\ \(0\)\
\-\ dressler\\:\\ 0\\.04279377875711892\ \(0\)\
\-\ 100cc\\:\\ 0\\.04279377875711892\ \(0\)\
\-\ stripe\\:\\ 0\\.040752251935181776\ \(0\)\
\-\ detect\\:\\ 0\\.037703390273593054\ \(0\)\
\-\ pericardium\\:\\ 0\\.028014543622539197\ \(0\)\
\-\ than\\:\\ 0\\.027172922996580993\ \(0\)\
\-\ differential\\:\\ 0\\.026339415818960477\ \(0\)\
\-\ chf\\:\\ 0\\.025969818063916364\ \(0\)\
\-\ cardiac\\:\\ 0\\.023700267909837164\ \(0\)\
\-\ lucent\\:\\ 0\\.022170015446199703\ \(0\)\
\-\ heart\\:\\ 0\\.021619512006617287\ \(0\)\
\-\ sign\\:\\ 0\\.02155664928468984\ \(0\)\
\-\ 200cc\\:\\ 0\\.02139688937855946\ \(0\)\
\-\ 50cc\\:\\ 0\\.02139688937855946\ \(0\)\
\-\ 2\\â\\€\\“8\\:\\ 0\\.02139688937855946\ \(0\)\
\-\ less\\:\\ 0\\.02107237867225254\ \(0\)\
\-\ density\\:\\ 0\\.02047304386063077\ \(0\)\
\-\ anteriorly\\:\\ 0\\.02034245442078751\ \(0\)\
\-\ border\\:\\ 0\\.019760127648559455\ \(0\)\
\-\ fib\\:\\ 0\\.019714493309239203\ \(0\)\
\-\ ptca\\:\\ 0\\.019714493309239203\ \(0\)\
\-\ 20cc\\:\\ 0\\.019714493309239203\ \(0\)\
\-\ posteriorly\\:\\ 0\\.0195941501497814\ \(0\)\
\-\ margin\\:\\ 0\\.019513242128008527\ \(0\)\
\-\ can\\:\\ 0\\.018817692742418148\ \(0\)\
\-\ maximally\\:\\ 0\\.018730354697326184\ \(0\)\
\-\ parietal\\:\\ 0\\.01772200218467468\ \(0\)\
\-\ fluid\\:\\ 0\\.01768426532478534\ \(0\)\
\-\ 2\\-3mm\\:\\ 0\\.01749048667847669\ \(0\)\
\-\ demonstated\\:\\ 0\\.017047958628005927\ \(0\)\
\-\ seen\\:\\ 0\\.016394442864734855\ \(0\)\
\-\ lasix\\:\\ 0\\.016063820016092908\ \(0\)\
\-\ film\\:\\ 0\\.015932664734169794\ \(0\)\
\-\ mi\\:\\ 0\\.015808090609156437\ \(0\)\
\-\ greater\\:\\ 0\\.015581147367332527\ \(0\)\
\-\ pt\\:\\ 0\\.015423125022489088\ \(0\)\
\-\ serosanguinous\\:\\ 0\\.015365562558685672\ \(0\)\
\-\ characterization\\:\\ 0\\.015171284142002332\ \(0\)\
\-\ is\\:\\ 0\\.015012617869495102\ \(0\)\
\-\ doses\\:\\ 0\\.014823951997243416\ \(0\)\
\-\ tamponade\\:\\ 0\\.014823951997243416\ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.014381423946772654\ \(0\)\
\-\ although\\:\\ 0\\.014009365439692249\ \(0\)\
\-\ it\\:\\ 0\\.013986760081551093\ \(0\)\
\-\ 4mm\\:\\ 0\\.013894359151961607\ \(0\)\
\-\ visceral\\:\\ 0\\.013786466524362495\ \(0\)\
\-\ serous\\:\\ 0\\.013786466524362495\ \(0\)\
\-\ space\\:\\ 0\\.013721150519789487\ \(0\)\
\-\ loculated\\:\\ 0\\.013584083978393925\ \(0\)\
\-\ plain\\:\\ 0\\.013472153945092642\ \(0\)\
\-\ lateral\\:\\ 0\\.013446611982703038\ \(0\)\
\-\ evacuation\\:\\ 0\\.013309014353862362\ \(0\)\
\-\ autoimmune\\:\\ 0\\.013223841247524327\ \(0\)\
\-\ echocardiography\\:\\ 0\\.013223841247524327\ \(0\)\
\-\ achieved\\:\\ 0\\.01314155592792316\ \(0\)\
\-\ le\\:\\ 0\\.01314155592792316\ \(0\)\
\-\ coumadin\\:\\ 0\\.01314155592792316\ \(0\)\
\-\ fibrillation\\:\\ 0\\.01314155592792316\ \(0\)\
\-\ identification\\:\\ 0\\.01306196897932367\ \(0\)\
\-\ inr\\:\\ 0\\.012984909031958182\ \(0\)\
\-\ myocardial\\:\\ 0\\.012699027877452397\ \(0\)\
\-\ \\,\\:\\ 0\\.012484202050554515\ \(0\)\
\-\ induced\\:\\ 0\\.012443298470515925\ \(0\)\
\-\ modalities\\:\\ 0\\.012443298470515925\ \(0\)\
\-\ for\\:\\ 0\\.012387759807036422\ \(0\)\
\-\ also\\:\\ 0\\.012266647526724404\ \(0\)\
\-\ demonstrated\\:\\ 0\\.012171941662412462\ \(0\)\
\-\ distant\\:\\ 0\\.01210407045504224\ \(0\)\
\-\ sob\\:\\ 0\\.01210407045504224\ \(0\)\
\-\ syndrome\\:\\ 0\\.011863624158906025\ \(0\)\
\-\ presumed\\:\\ 0\\.011760258520423244\ \(0\)\
\-\ 76\\:\\ 0\\.011714889265539378\ \(0\)\
\-\ therapeutic\\:\\ 0\\.011670352521199094\ \(0\)\
\-\ include\\:\\ 0\\.01163666741762275\ \(0\)\
\-\ configuration\\:\\ 0\\.01158365814595133\ \(0\)\
\-\ 63\\:\\ 0\\.011499953835098976\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.011379572910003414\ \(0\)\
\-\ consists\\:\\ 0\\.011379572910003414\ \(0\)\
\-\ sensitive\\:\\ 0\\.011264881441919564\ \(0\)\
\-\ developing\\:\\ 0\\.010853672335225276\ \(0\)\
\-\ shape\\:\\ 0\\.010791433425969603\ \(0\)\
\-\ thickness\\:\\ 0\\.010700968875490885\ \(0\)\
\-\ better\\:\\ 0\\.010700968875490885\ \(0\)\
\-\ drug\\:\\ 0\\.010642479672629086\ \(0\)\
\-\ possibly\\:\\ 0\\.010613755260864518\ \(0\)\
\-\ neoplastic\\:\\ 0\\.010613755260864518\ \(0\)\
\-\ atrial\\:\\ 0\\.010613755260864518\ \(0\)\
\-\ relief\\:\\ 0\\.010585366814837354\ \(0\)\
\-\ next\\:\\ 0\\.010529567013321094\ \(0\)\
\-\ metabolic\\:\\ 0\\.010243685858815311\ \(0\)\
\-\ normally\\:\\ 0\\.010219291839753413\ \(0\)\
\-\ dissection\\:\\ 0\\.01019514055127485\ \(0\)\
\-\ entire\\:\\ 0\\.01019514055127485\ \(0\)\
\-\ chest\\:\\ 0\\.009925868932318052\ \(0\)\
\-\ without\\:\\ 0\\.009767054205622136\ \(0\)\
\-\ \\%\\:\\ 0\\.009676315695854405\ \(0\)\
\-\ a\\:\\ 0\\.009626208782004885\ \(0\)\
\-\ was\\:\\ 0\\.009594927400132881\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.009368182928070965\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.009351149984724734\ \(0\)\
\-\ thickened\\:\\ 0\\.00930075680159748\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009061267969190222\ \(0\)\
\-\ needed\\:\\ 0\\.009033418017378\ \(0\)\
\-\ had\\:\\ 0\\.008950727277867514\ \(0\)\
\-\ infectious\\:\\ 0\\.008917123464718053\ \(0\)\
\-\ cxr\\:\\ 0\\.008752505512439508\ \(0\)\
\-\ increase\\:\\ 0\\.008700023803669688\ \(0\)\
\-\ pa\\:\\ 0\\.008674202448803047\ \(0\)\
\-\ around\\:\\ 0\\.008635978281404652\ \(0\)\
\-\ specific\\:\\ 0\\.008573579357350751\ \(0\)\
\-\ increasing\\:\\ 0\\.008500758361467744\ \(0\)\
\-\ infarction\\:\\ 0\\.008476962244728372\ \(0\)\
\-\ aortic\\:\\ 0\\.008395466381782731\ \(0\)\
\-\ range\\:\\ 0\\.008350097126898865\ \(0\)\
\-\ sounds\\:\\ 0\\.008272686049772765\ \(0\)\
\-\ 15\\:\\ 0\\.008272686049772765\ \(0\)\
\-\ causes\\:\\ 0\\.008074224994684008\ \(0\)\
\-\ pleural\\:\\ 0\\.008054248055032272\ \(0\)\
\-\ rare\\:\\ 0\\.008054248055032272\ \(0\)\
\-\ about\\:\\ 0\\.007995285208990902\ \(0\)\
\-\ within\\:\\ 0\\.007913259264010104\ \(0\)\
\-\ view\\:\\ 0\\.007781666574712472\ \(0\)\
\-\ ventricle\\:\\ 0\\.007772792032957348\ \(0\)\
\-\ which\\:\\ 0\\.007743420326420138\ \(0\)\
\-\ abnormality\\:\\ 0\\.007651839669491631\ \(0\)\
\-\ mm\\:\\ 0\\.0076266872737742845\ \(0\)\
\-\ since\\:\\ 0\\.007618360732277224\ \(0\)\
\-\ dilated\\:\\ 0\\.007536629627649584\ \(0\)\
\-\ or\\:\\ 0\\.007292641375949327\ \(0\)\
\-\ enlarged\\:\\ 0\\.0070767501708349665\ \(0\)\
\-\ thickening\\:\\ 0\\.007030642159449882\ \(0\)\
\-\ on\\:\\ 0\\.007028068081217748\ \(0\)\
\-\ cause\\:\\ 0\\.007017627734349431\ \(0\)\
\-\ swelling\\:\\ 0\\.006909735106750321\ \(0\)\
\-\ by\\:\\ 0\\.006907140307013954\ \(0\)\
\-\ \\>\\:\\ 0\\.006891183288030496\ \(0\)\
\-\ along\\:\\ 0\\.006854499701112903\ \(0\)\
\-\ mr\\:\\ 0\\.006590289980452509\ \(0\)\
\-\ between\\:\\ 0\\.006574018291806417\ \(0\)\
\-\ will\\:\\ 0\\.006489031598007625\ \(0\)\
\-\ usually\\:\\ 0\\.0062983695482202885\ \(0\)\
\-\ yo\\:\\ 0\\.006241144474035829\ \(0\)\
\-\ treated\\:\\ 0\\.006208375815737522\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.006199094028265669\ \(0\)\
\-\ s\\:\\ 0\\.005948465211443172\ \(0\)\
\-\ following\\:\\ 0\\.005886596497332884\ \(0\)\
\-\ weeks\\:\\ 0\\.005886596497332884\ \(0\)\
\-\ time\\:\\ 0\\.005858255405920661\ \(0\)\
\-\ chronic\\:\\ 0\\.00584220784686165\ \(0\)\
\-\ ct\\:\\ 0\\.005802444919378849\ \(0\)\
\-\ he\\:\\ 0\\.005786862480662668\ \(0\)\
\-\ an\\:\\ 0\\.0057362372052656785\ \(0\)\
\-\ the\\:\\ 0\\.005704460776605919\ \(0\)\
\-\ trauma\\:\\ 0\\.005672351412033808\ \(0\)\
\-\ months\\:\\ 0\\.005664906055072978\ \(0\)\
\-\ presented\\:\\ 0\\.005653780667530119\ \(0\)\
\-\ been\\:\\ 0\\.005642706042388327\ \(0\)\
\-\ significant\\:\\ 0\\.005577298910325784\ \(0\)\
\-\ enhancement\\:\\ 0\\.005559438752725815\ \(0\)\
\-\ \\:\\:\\ 0\\.0054867709514109944\ \(0\)\
\-\ common\\:\\ 0\\.005427833038729119\ \(0\)\
\-\ patients\\:\\ 0\\.005367899513024334\ \(0\)\
\-\ anterior\\:\\ 0\\.005341730154763925\ \(0\)\
\-\ prior\\:\\ 0\\.005325516437384377\ \(0\)\
\-\ more\\:\\ 0\\.0051873211391072\ \(0\)\
\-\ acute\\:\\ 0\\.005121066332782755\ \(0\)\
\-\ physical\\:\\ 0\\.005088605023255433\ \(0\)\
\-\ 3\\:\\ 0\\.004856736715307135\ \(0\)\
\-\ and\\:\\ 0\\.00480606568702525\ \(0\)\
\-\ most\\:\\ 0\\.004788434810019602\ \(0\)\
\-\ posterior\\:\\ 0\\.004780676089083613\ \(0\)\
\-\ other\\:\\ 0\\.004780676089083613\ \(0\)\
\-\ this\\:\\ 0\\.004665714627738509\ \(0\)\
\-\ \\'s\\:\\ 0\\.004572928685356905\ \(0\)\
\-\ exam\\:\\ 0\\.004556393058129947\ \(0\)\
\-\ may\\:\\ 0\\.004549340701209038\ \(0\)\
\-\ large\\:\\ 0\\.004535297164638543\ \(0\)\
\-\ have\\:\\ 0\\.004491354559138572\ \(0\)\
\-\ 2\\:\\ 0\\.004466273049782879\ \(0\)\
\-\ but\\:\\ 0\\.004423551701537712\ \(0\)\
\-\ findings\\:\\ 0\\.004414652756771747\ \(0\)\
\-\ surgical\\:\\ 0\\.004359761578280227\ \(0\)\
\-\ after\\:\\ 0\\.004291265054876705\ \(0\)\
\-\ treatment\\:\\ 0\\.004198099416507007\ \(0\)\
\-\ in\\:\\ 0\\.0040912352440801445\ \(0\)\
\-\ male\\:\\ 0\\.003750498878367653\ \(0\)\
\-\ that\\:\\ 0\\.003582477496501998\ \(0\)\
\-\ be\\:\\ 0\\.0031984386488930314\ \(0\)\
\-\ of\\:\\ 0\\.0031105383708200794\ \(0\)\
\-\ pain\\:\\ 0\\.002533029532841589\ \(0\)\
\-\ with\\:\\ 0\\.0019879350306534664\ \(0\)\
\-\ \\.\\:\\ 0\\.0018956062964602379\ \(0\)\
\-\ to\\:\\ 0\\.0010365730787451123\ \(0\)\
